Management of del(5q) MDS

被引：1
|
作者：
Giagounidis, A. [1 ]
机构：
[1] St Johannes Hosp, Duisburg, Germany
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70035-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [1] The questions on megakaryopoiesis in MDS patients with del(5q)
    Neuwirtova, R.
    Jonasova, A.
    Cermak, J.
    Vondrakova, J.
    Hochova, I.
    Jungova, A.
    Belohlavkova, P.
    Siskova, M.
    Kadlckova, E.
    Cerna, O.
    Smolikova, A.
    Polonyova, E.
    Bruchova, H.
    Zemanova, Z.
    Mikulenkova, D.
    LEUKEMIA RESEARCH, 2009, 33 : S105 - S105
  • [2] MDS with isolated del(5q) and internuclear bridging
    Xu, Zhaodong
    McGowan-Jordan, Jean
    BLOOD, 2017, 129 (16) : 2333 - 2333
  • [3] Errant innate immune signaling in del(5q) MDS
    Starczynowski, Daniel T.
    BLOOD, 2014, 124 (05) : 669 - 671
  • [4] Refining remission evaluation in MDS with isolated del(5q)
    Bill, Marie
    Kjeldsen, Eigil
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (04) : 469 - 470
  • [5] Variability in the extent of del(5q) in myelodysplastic syndromes (MDS)
    Zemanova, Zuzana
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Vesela, Denisa
    Belickova, Monika
    Vesela, Jitka
    Izakova, Silvia
    Sarova, Iveta
    Lizcova, Libuse
    Ransdorfova, Sarka
    Pavlistova, Lenka
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    Michalova, Kyra
    MOLECULAR CYTOGENETICS, 2019, 12
  • [6] Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases
    Smoljanovic, Inga Mandac
    Taylor, Adele
    Fenaux, Pierre
    Guerci-Bresler, Agnes
    Itzykson, Raphael
    Symeonidis, Argiris
    Kotsianidis, Ioannis
    Mittelman, Moshe
    Sanz, Guillermo
    Culligan, Dominic J.
    Cermak, Jaroslav
    Stauder, Reinhard
    Hellstrom-Lindberg, Eva
    Malcovati, Luca
    Langemeijer, Saskia M. C.
    Germing, Ulrich
    Madry, Krzysztof
    Oster, Howard S.
    Smith, Alexandra
    van Marrewijk, Corine
    de Witte, Theo M.
    Bowen, David
    BLOOD, 2022, 140 : 9802 - 9803
  • [7] MONITORING OF THERAPEUTIC RESPONSE TO LENALIDOMIDE IN DEL(5Q) MDS USING A RAPID 5-PARAMETER FLOW CYTOMETRIC DEL(5Q)-SCORE
    Oelschlaegel, U.
    Mohr, B.
    Sockel, K.
    Thiede, C.
    Ehninger, G.
    Bornhaeuser, M.
    Platzbecker, U.
    LEUKEMIA RESEARCH, 2015, 39 : S55 - S55
  • [8] Prognostic value of low platelets in MDS patients with del(5q)
    Galili, N.
    Ahmed, A.
    Quddus, F.
    Jandani, S.
    Gul, Z.
    Siddiki, A.
    Mumtaz, M.
    Mehdi, M.
    Devuni, D.
    Raza, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Loss of CTNNA1 in MDS and/or AML with del(5q)
    Liu, TX
    Becker, MW
    Hsu, K
    Deng, M
    Clarke, MF
    Look, AT
    BLOOD CELLS MOLECULES AND DISEASES, 2004, 33 (02) : 103 - 103
  • [10] Acute basophilic leukaemia secondary to MDS with isolated del(5q)
    Loyola, Ines
    Fernandez, Raquel
    Trastoy, Ariana
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 817 - 817
12345